Neurologic - Ipsen
Neurologic
Status:
Open/EnrollingClinicalTrials.gov:
NCT06047444A Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study With Extension Phase to Evaluate the Efficacy and Safety of Dysport® for the Prevention of Chronic Migraine in Adult Participants